Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 4, 2006, Pages 1275-1283

  Leibel, Natasha I ^a   Baumann, Elizabeth E ^a   Kocherginsky, Masha ^c   Rosenfield, Robert L ^a,b,d  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; BLOOD; CHILD; DYSLIPIDEMIA; FATHER; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LIPID METABOLISM; MALE; METABOLISM; MIDDLE AGED; OBESITY; PARENT; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANDROGEN;

ADOLESCENT; ADULT; ANDROGENS; ANTHROPOMETRY; BLOOD PRESSURE; CHILD; DYSLIPIDEMIAS; FATHERS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PARENTS; PHENOTYPE; POLYCYSTIC OVARY SYNDROME;

EID: 33646029745     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-1707     Document Type: Article

References (72)

1. Ehrmann DA, Barnes RB, Rosenfield RL 1995 Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16:322-353
2. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745-2749
3. Dunaif A, Segal KR, Futterweit W, Dobrjansky A 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174
4. Ehrmann DA, Jeppe S, Byrne M, Karrison T, Rosenfield RL, Polonsky K 1995 Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest 96:520-527
5. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J 1999 Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141-146
6. Legro RS, Kunselman AR, Dodson WC, Dunaif A 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165-169
7. Glueck CJ, Papanna R, Wang P, Goldenberg N, Sieve-Smith L 2003 Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism 52:908-915
8. Orio F, Jr., Palomba S, Spinelli L, Cascella T, Tauchmanova L, Zullo F, Lombardi G, Colao A 2004 The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective casecontrol study. J Clin Endocrinol Metab 89:3696-3701
9. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
10. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE 2005 Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:1929-1935
11. Legro RS, Strauss JF 2002 Molecular progress in infertility: polycystic ovary syndrome. Fertil Steril 78:569-576
12. Carey AH, Chan KL, Short F, White D, Williamson R, Franks S 1993 Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol (Oxf) 38:653-658
13. Govind A, Obhrai MS, Clayton RN 1999 Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab 84:38-43
14. Yildiz BO, Yarali H, Oguz H, Bayraktar M 2003 Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:2031-2036
15. Kahsar-Miller MD, Nixon C, Boots LR, Go RC, Azziz R 2001 Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril 75:53-58
16. Colilla S, Cox NJ, Ehrmann DA 2001 Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. J Clin Endocrinol Metab 86:2027-2031
17. Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C 2004 Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433-438
18. Eckel RH, Grundy SM, Zimmet PZ 2005 The metabolic syndrome. Lancet 365:1415-1428
19. Balen AH, Laven JS, Tan SL, Dewailly D 2003 Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9:505-514
20. Venturoli S, Porcu E, Fabbri R, Pluchinotta V, Ruggeri S, Macrelli S, Paradisi R, Flamigni C 1995 Longitudinal change of sonographic ovarian aspects and endocrine parameters in irregular cycles of adolescence. Pediatr Res 38:974-980
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497
22. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH 2003 Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 157:821-827
23. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS 2003 Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76-79
24. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB 2003 The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163:427-436
25. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD 1998 Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21:518-524
26. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM 2004 Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291:2847-2850
27. National Center for Health Statistics 2004 National Health and Nutrition Examination Survey III. Anthropometric reference data, United States, 1988-1994. Hyattsville, MD: U.S. Department of Health and Human Services
28. Fernandez JR, Redden DT, Pietrobelli A, Allison DB 2004 Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 145:439-444
29. Callaway CW, Chumlea WC, Bouchard C, Himes JH, Lohman TG, Martin AD, Mitchell CD, Mueller WH, Roche AF, Seefeldt VD 1988 Circumferences. In: Lohman TG, Roche AF, Martorell R, eds. Anthropometric standardization reference manual. Champaign, IL: Human Kinetics Books; 39-54
30. Rosenfield RL, Perovic N, Ehrmann DA, Barnes RB 1996 Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose response studies and comparison to nafarelin. J Clin Endocrinol Metab 81:3408-3411
31. Moll Jr G, Rosenfield R 1979 Testosterone binding and free plasma androgen concentrations under physiological conditions: characterization by flow dialysis technique. J Clin Endocrinol Metab 49:730-736
32. American DA 2004 Diagnosis and classification of diabetes mellitus. Diabetes Care 27(Suppl 1):S5-S10
33. Faber O, Binder C, Markussen J, Heding L, Naithani V, Kuzuga H, Blix P, Horwitz D, Rubenstein A 1978 Characterization of seven C-peptide antisera. Diabetes 27:170-177
34. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
35. Altman DG 1999 Practical statistics for medical research. Boca Raton, FL: CRC Press
36. Cuzick J 1985 A Wilcoxon-type test for trend. Stat Med 4:87-90
37. Apter D, Bützow G, Laughlin A, Yen SSC 1995 Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J Clin Endocrinol Metab 80:2966-2973
38. Rosenfield RL, Ghai K, Ehrmann DA, Barnes RB 2000 Diagnosis of polycystic ovary syndrome in adolescence. Comparison of adolescent and adult hyperandrogenism. J Pediatr Endocrinol Metab 13:1285-1289
39. Silfen ME, Denburg MR, Manibo AM, Lobo RA, Jaffe R, Ferin M, Levine LS, Oberfield SE 2003 Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab 88:4682-4688
40. Trent M, Austin SB, Rich M, Gordon CM 2005 Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambul Pediatr 5:107-111
41. Arslanian SA, Lewy VD, Danadian K 2001 Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab 86:66-71
42. Lewy VD, Danadian K, Witchel SF, Arslanian S 2001 Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J Pediatr 138:38-44
43. Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emans SJ, Dunaif A 2002 Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 87:1017-1023
44. Figueroa-Colon R, Arani RB, Goran MI, Weinsier RL 2000 Paternal body fat is a longitudinal predictor of changes in body fat in premenarcheal girls. Am J Clin Nutr 71:829-834
45. Sir-Petermann T, Angel B, Maliqueo M, Carvajal F, Santos JL, Perez-Bravo F 2002 Prevalence of type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome. Diabetologia 45:959-964
46. Sam S, Legro RS, Bentley-Lewis R, Dunaif A 2005 Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:4797-4802
47. Franks S, Gharani N, Waterworth D, Batty S, White D, Williamson R, McCarthy M 1998 Genetics of polycystic ovary syndrome. Mol Cell Endocrinol 145:123-128
48. Legro RS, Driscoll D, Strauss 3rd JF, Fox J, Dunaif A 1998 Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 95:14956-14960
49. Giacobbe M, Pinto-Neto AM, Costa-Paiva LH, Martinez EZ 2004 Ovarian volume, age, and menopausal status. Menopause 11:180-185
50. Tufan E, Elter K, Durmusoglu F 2004 Assessment of reproductive ageing patterns by hormonal and ultrasonographic ovarian reserve tests. Hum Reprod 19:2484-2489
51. Winters SJ, Talbott E, Guzick DS, Zborowski J, McHugh KP 2000 Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. Fertil Steril 73:724-729
52. Davison SL, Bell R, Donath S, Montalto JG, Davis SR 2005 Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90:3847-3853
53. Ferriman D, Purdie A 1979 The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clin Endocrinol (Oxf) 11:291-300
54. Nyholt DR, Gillespie NA, Heath AC, Martin NG 2003 Genetic basis of male pattern baldness. J Invest Dermatol 121:1561-1564
55. Legro RS, Kunselman AR, Demers L, Wang SC, Bentley-Lewis R, Dunaif A 2002 Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. J Clin Endocrinol Metab 87:2134-2138
56. Hong Y, Weisnagel SJ, Rice T, Sun G, Mandel SA, Gu C, Rankinen T, Gagnon J, Leon AS, Skinner JS, Wilmore JH, Bergman RN, Bouchard C, Rao DC 2001 Familial resemblance for glucose and insulin metabolism indices derived from an intravenous glucose tolerance test in Blacks and Whites of the HERITAGE Family Study. Clin Genet 60:22-30
57. An P, Rice T, Gagnon J, Borecki IB, Rankinen T, Gu C, Leon AS, Skinner JS, Wilmore JH, Bouchard C, Rao DC 2001 Population differences in the pattern of familial aggregation for sex hormone-binding globulin and its response to exercise training: the HERITAGE Family Study. Am J Hum Biol 13:832-837
58. Hong Y, Gagnon J, Rice T, Perusse L, Leon AS, Skinner JS, Wilmore JH, Bouchard C, Rao DC 2001 Familial resemblance for free androgens and androgen glucuronides in sedentary black and white individuals: the HERITAGE Family Study. Health, Risk Factors, Exercise Training and Genetics. J Endocrinol 170:485-492
59. Nestler J, Powers L, Matt D, Steingold K, Plymate S, Rittmaster R, Clore J, Blackard W 1991 A direct effect of hyperinsulinemia on serum sex-hormone binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 72:83-89
60. Ehrmann DA 2004 Medical progress: polycystic ovary syndrome. N Engl J Med 352:1223-1236
61. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R 1998 Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83:3078-3082
62. Carmina E, Legro RS, Stamets K, Lowell J, Lobo RA 2003 Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod 18:2289-2293
63. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF 2000 A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434-2438
64. Ibañez L, Valls C, Potau N, Marcos M, De Zegher F 2001 Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect. Clin Endocrinol (Oxf) 55:667-672
65. Kirchengast S, Huber J 2001 Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod 16:1255-1260
66. Polson D, Adams J, Wadsworth J, Franks S 1988 Polycystic ovaries: a common finding in normal women. Lancet 1:870-872
67. Legro RS, Chiu P, Kunselman AR, Bentley CM, Dodson WC, Dunaif A 2005 Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. J Clin Endocrinol Metab 90:2571-2579
68. Adams JM, Taylor AE, Crowley Jr WF, Hall JE 2004 Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab 89:4343-4350
69. van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J 2004 Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years. Hum Reprod 19:383-392
70. Mendelson EB, Bohm-Velez M, Joseph N, Neiman HL 1988 Gynecologic imaging: comparison of transabdominal and transvaginal sonography. Radiology 166:321-324
71. Block E 1953 A quantitative morphological investigation of the follicular system in newborn female infants. Acta Anat 17:201-206
72. Baker T 1963 A quantitative and cytological study of germ cells in human ovaries. Proc Roy Soc Biol 158:417-433